ASCOnivolumab

Home Tag

Ok_elegida_por_ella

CheckMate 9ER: extended follow-up data further supports nivolumab plus cabozantinib as first-line treatment of advanced renal cell carcinoma

The phase III international CheckMate 9ER trial continues to make headlines. Now published ahead of print in The Lancet Oncology…